LinkedIn
Facebook
H1 2025 Results
- 01 July 2025 - 0 mins read
An investor and analyst conference call will follow at 13:00 CET.
Key highlights
31 July 2025
31 July 2025
About Ipsen
We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries, and our partnerships around the world, enable us to bring medicines to patients in more than 100 countries.
Ipsen in brief
Discover Ipsen in 3 pages; our medicines and key figures, our objectives and our strategy.
If you are experiencing difficulties registering for the investor and analyst conference call, please contact: khalid.deojee@ipsen.com
How useful was this post?
Click on a star to rate it!
